Plain-English translation of NCT07427017 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether selenomethionine, a naturally occurring mineral that you can buy as a dietary supplement, helps control ulcerative colitis inflammation when taken alongside advanced anti-inflammatory medications. Ulcerative colitis is a condition where the colon becomes inflamed and causes painful symptoms like bloody diarrhea. The researchers want to see if this simple, over-the-counter supplement can reduce flare-ups and improve how well you feel when combined with the stronger medications your doctor may prescribe.
Studies suggest that people with ulcerative colitis often don't have enough of this mineral in their bodies, and low levels are linked to worse flare-ups and even the need for surgery. Since this medication is inexpensive, naturally found in foods, and already available at any drugstore, doctors would like to know if recommending it could help patients do better without causing harm.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will take either selenomethionine or a placebo pill โ one tablet daily for 12 weeks โ starting within one week after you begin your advanced ulcerative colitis medication. Neither you nor the study team will know which group you're in (this is called a 'blind' study, which helps keep results fair). You'll likely have clinic visits to check how you're doing, discuss your symptoms, and have blood tests or other assessments as part of standard care for your condition.
AI-generated summary from trial data ยท Jun 2, 2026 ยท Not medical advice
United States